期刊文献+

β受体亚型及其信号通路干预治疗慢性心力衰竭研究进展 被引量:2

Effects of Adrenoreceptor Subtype and Its Signaling in Heart Failure
下载PDF
导出
摘要 β受体在心力衰竭中发挥十分重要的作用。目前,β受体亚型及其信号通路成为心力衰竭发病机制的研究热点,对其亚型及其通路干预治疗慢性心力衰竭有望成为将来的主要治疗方向。 The adrenoreceptor plays a vital role in heart failure. At present, the adreno-receptor subtype and its signaling becomes a hot spot in the pathogenesis of heart failure. Intervention focused on the adrenoreeeptor subtype and its signaling, may be the main therapeutic trend in chronic heart failure.
出处 《心血管病学进展》 CAS 2009年第1期151-153,共3页 Advances in Cardiovascular Diseases
基金 黑龙江省科技厅国际合作重点项目(WB07C01) 黑龙江省卫生厅资助项目(2006-010) 黑龙江省教育厅资助项目(11531108) 哈医大一院资助项目(2007106)
关键词 β受体亚型 信号通路 心力衰竭 β-adrenoreeeptor subtype signaling heart failure
  • 相关文献

参考文献18

  • 1Dorn GW 2nd, Tepe NM, Lorenz JN, et al. Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gotq-overexpressing mice [J ]. Proc Natl Acad Sci USA, 1999,96 ( 11 ) :6400-6405.
  • 2Xiao RP, Zhang S J, Chakir K, et al. Enhanced G ( i ) signaling selectively negates beta2-adrenergic receptor (AR)--but not betal-AR-medlated positive inotropic effect in myocytes from failing rat hearts[ J ]. Circulation,2003,108:1633-1639.
  • 3Ahmet I, Krawczyk M, Heller P, et al. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy[ J ]. Circulation ,2004,110 (9) : I083-1090.
  • 4李为民,甘润韬,王旭,吴双,沈景霞,修春红.β_1肾上腺素能受体阻断剂与β_2肾上腺素能受体激动剂联用对心力衰竭大鼠心功能及心肌细胞凋亡的影响[J].中华心血管病杂志,2007,35(7):615-619. 被引量:9
  • 5Morimoto A, Hasegawa H, Cheng H J, et al. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure[ J]. Am J Physiol Heart Circ Physiol,2004,286(6) :H2425-2433.
  • 6Drazner MH, Peppel KC, Dyer S, et al. Potentiation of beta-adrenergie signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes [ J ]. J Clin Invest,1997,99(2) :288-296.
  • 7Harding V, Jones L, Lefkowitz R J, et al. Cardiac βARK1 inhibition prolongs survival and augments β-blocker therapy in a mouse model of severe heart failure [ J]. Proc Natl Acad Sci USA,2001,98(10) :5809-5814.
  • 8Williams ML, Hata JA, Schroder J, et al. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts[ J]. Circulation ,2004,109 ( 13 ) : 1590-1593.
  • 9Roth DM, Bayat H, Drumm JD,et al. Adenylyl cyclase increases survival in cardiomyopathy [ J]. Circulation ,2002,105 (16) : 1989-1994.
  • 10Lai NC, Roth DM, Gao MH, et al. lntracoronary adenovirus encoding adenylyl cyclase Ⅵ increases left ventricular function in heart failure [ J ]. Circulation, 2004,110 ( 3 ) : 330-336.

二级参考文献14

  • 1Communal C, Singh K, Sawyer DB, et al. Opposing effects of beta( 1 )- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. Circulation, 1999, 100(22):2210-2212.
  • 2Zaugg M, Xu W, Lucchinetti E, et al. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation, 2000, 102(3) : 344-350.
  • 3Milano CA, Allen LF, Rockman HA, et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science, 1994,264 (5158 ) :582-586.
  • 4Dora GW 2nd, Tepe NM, Lorenz JN, et al. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc Natl Acad Sci U S A , 1999, 96(11) : 6400-6405.
  • 5Ahmet I, Krawczyk M, Heller P, et al. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation, 2004, 110(9) : 1083-1090.
  • 6Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse iseproterenol-induced myocardial necrosis in rats. Circ Res,1994, 75(1) : 105-113.
  • 7Ahmet I, Lakatta EG, Talan MI. Pharmacological stimulation of beta2-adrenergic receptors ( beta2AB ) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev, 2005, 10(4) :289-296.
  • 8Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest,2003 , 111 (10) : 1497-1504.
  • 9Xydas S, Kherani AR, Chang JS, et al. beta ( 2 ) -Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther, 2006, 317(2) : 553-561.
  • 10Chesley A, Lundberg MS, Asai T, et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G (i)-dependent coupling to phosphatidylinositol 3'- kinase. Circ Res, 2000, 87(12) : 1172-1179.

共引文献8

同被引文献21

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部